Most Read Articles
Stephen Padilla, 5 days ago
Local clusters of the 2019 coronavirus disease (COVID-19) can be expected in countries with high travel volume from China before the lockdown of Wuhan and the institution of travel restrictions, according to a study in Singapore, wherein three initial clusters had been identified in February 2020: a tour group from China, a company conference, and a church.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
5 days ago
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.
Tristan Manalac, 5 days ago
Asymptomatic carriage of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is more likely among middle-aged adults, according to a new Shenzhen, China study. In these cases, the disease turned out to be mostly mild in severity.

Highlights from the 13th International Congress of the Asian Society Against Dementia & 6th Singapore International Neuro-Cognitive Symposium

11 Dec 2019
The Schwabe Pharma lunch symposium was held on 30 August 2019, in conjunction with the 13th International Congress of the Asian Society Against Dementia & 6th Singapore International Neuro-Cognitive Symposium. Professor Serge Gauthier and Associate Professor Nagaendran Kandiah were invited as honourable speakers to this symposium to share the latest evidence on the current and potential role of Ginkgo biloba extract (EGb 761®), an anti-dementia agent, in the treatment of dementia and mild cognitive impairment (MCI).
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Singapore digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 5 days ago
Local clusters of the 2019 coronavirus disease (COVID-19) can be expected in countries with high travel volume from China before the lockdown of Wuhan and the institution of travel restrictions, according to a study in Singapore, wherein three initial clusters had been identified in February 2020: a tour group from China, a company conference, and a church.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
5 days ago
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.
Tristan Manalac, 5 days ago
Asymptomatic carriage of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is more likely among middle-aged adults, according to a new Shenzhen, China study. In these cases, the disease turned out to be mostly mild in severity.